Here is a list of direct-acting antiviral drugs (DAAs), their FDA-approved usage / indications, and the side effects that we are currently investigating:
Harvoni / Sovaldi / Viekira Pak / Technivie / Olysio / Daklinza / Epclusa / Zepatier
Prescribed/Used for:
Treatment of Hepatitis C Virus (HCV)
-Sovaldi (sofosbuvir)
-Harvoni (ledipasvir / sofosbuvir)
-Viekira Pak (dasabuvir / ombitasvir / paritaprevir / ritonavir)
-Viekira XR (dasabuvir / ombitasvir / paritaprevir / ritonavir)
-Technivie (ombitasvir / paritaprevir / ritonavir)
-Olysio (simeprevir)
-Daklinza (daclatasvir)
-Zepatier (elbasvir / grazoprevir)
-Epclusa (sofosbuvir / velpatasvir)
Side Effects We Are Currently Investigating:
-Liver failure
-Acute liver injury
-Severe liver damage
-Reactivation of Hepatitis B
Recent articles by attorney Tom Lamb on the Drug Injury Law web site:
- No Link Seen Between Sovaldi Or Harvoni And Liver Cancer Recurrence
- Can Hepatitis C Drugs Harvoni Or Sovaldi Cause Return Of Liver Cancer?
- Sovaldi / Harvoni: “Black-Box” Warning About Hepatitis B Reactivation
- Newer Hepatitis C Drugs Harvoni And Sovaldi Could Cause Liver Failure
- Is The Risk Of Liver Cancer Increased From Use Of Harvoni Or Sovaldi?
- Black-Box Warning For Harvoni, Sovaldi, Viekira Pak: Hepatitis B Risk
Go to Drug Injury or Death Case Evaluation for Harvoni / Sovaldi / Viekira Pak / Viekira XR / Technivie / Olysio / Daklinza / Epclusa / Zepatier Drug Injury or Death Case Evaluation
Go to Drug Injury Law for more information